Recent Finacing
Recent Raise
MPC Therapeutics, spun out of the University of Geneva, develops MPC‑inhibiting small molecules to modulate mitochondria, advancing a CAR‑T adjuvant in preclinical cancer models and alopecia applications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at MPC Therapeutics.
